Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections
Amandine Crequer, … , Jean-Laurent Casanova, Emmanuelle Jouanguy
Amandine Crequer, … , Jean-Laurent Casanova, Emmanuelle Jouanguy
Published August 1, 2012
Citation Information: J Clin Invest. 2012;122(9):3239-3247. https://doi.org/10.1172/JCI62949.
View: Text | PDF
Research Article Immunology

Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections

  • Text
  • PDF
Abstract

Epidermodysplasia verruciformis (EV) is a rare genetic disorder characterized by increased susceptibility to specific human papillomaviruses, the betapapillomaviruses. These EV-HPVs cause warts and increase the risk of skin carcinomas in otherwise healthy individuals. Inactivating mutations in epidermodysplasia verruciformis 1 (EVER1) or EVER2 have been identified in most, but not all, patients with autosomal recessive EV. We found that 2 young adult siblings presenting with T cell deficiency and various infectious diseases, including persistent EV-HPV infections, were homozygous for a mutation creating a stop codon in the ras homolog gene family member H (RHOH) gene. RHOH encodes an atypical Rho GTPase expressed predominantly in hematopoietic cells. Patients’ circulating T cells contained predominantly effector memory T cells, which displayed impaired TCR signaling. Additionally, very few circulating T cells expressed the β7 integrin subunit, which homes T cells to specific tissues. Similarly, Rhoh-null mice exhibited a severe overall T cell defect and abnormally small numbers of circulating β7-positive cells. Expression of the WT, but not of the mutated RHOH, allele in Rhoh–/– hematopoietic stem cells corrected the T cell lymphopenia in mice after bone marrow transplantation. We conclude that RHOH deficiency leads to T cell defects and persistent EV-HPV infections, suggesting that T cells play a role in the pathogenesis of chronic EV-HPV infections.

Authors

Amandine Crequer, Anja Troeger, Etienne Patin, Cindy S. Ma, Capucine Picard, Vincent Pedergnana, Claire Fieschi, Annick Lim, Avinash Abhyankar, Laure Gineau, Ingrid Mueller-Fleckenstein, Monika Schmidt, Alain Taieb, James Krueger, Laurent Abel, Stuart G. Tangye, Gérard Orth, David A. Williams, Jean-Laurent Casanova, Emmanuelle Jouanguy

×

Figure 3

Human and mouse RHOH deficiencies lead to an abnormal integrin expression pattern.

Options: View larger image (or click on image) Download as PowerPoint
Human and mouse RHOH deficiencies lead to an abnormal integrin expressio...
(A–E) Tissue-homing T cell subsets were assessed on live CD3+-, CD3+CD4+-, and CD3+CD8+-gated cryopreserved PBMCs from the 2 patients (P1 values indicated by gray squares, P2 values indicated by gray diamonds) and healthy controls (indicated by black circles) by flow cytometry. (A) Skin-homing CLA+ subsets were assessed for both patients and 28 healthy controls. (B) CCR4+, CCR6+, and CCR10+ subsets were assessed for both patients and 12, 17, and 12 healthy controls, respectively. (C) Skin-homing CLA+CCR4+, CLA+CCR6+, and CLA+CCR10+ subsets were assessed for both patients and for 12, 17, and 12 healthy controls, respectively. (D) αE+β7+ cells were assessed for both patients and 14 healthy controls. (E) β7+, α4+, α4+β7+, and α4+β7– subsets were assessed for both patients and 12 healthy controls. The frequencies of the various subsets are expressed in percentages of CD3+ cells. Viability rates were about 95% for all PBMC preparations. Patients’ samples were tested at least twice, except for the chemokine receptors, for which assessments were carried out only once. Mean values are indicated by horizontal bars. The values obtained in all experiments were similar. (F) The frequencies within the CD3+ population of β7+, α4+, αE+β7+, and α4+β7+ cells were assessed by flow cytometry on CD3+-gated peripheral blood cells from Rhoh+/+ (n = 5) and Rhoh–/– mice (mean ± SEM, n = 5 mice of mixed background). *P < 0.05; **P < 0.005; ***P < 0.0005.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts